Market Overview:
Middle-East and Africa Colorectal Cancer Market has been evaluated as steadily growing market and it is expected that the market will continue to grow at same pace in the near future. Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers can also know as colon cancer or rectal cancer, depending on where they start. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, Diarrhea, Pains in the abdomen, Vomiting, and feeling tired all the time.
Globally, around 1.4 million people diagnosed in 2014, in Middle-East and Africa approximately 5000 are suffering from Colorectal Cancer throughout Middle-East and Africa. About 80% of orphan disorders are genetic origin. Rising consumer awareness and continuous development of treatment for Colorectal Cancer are driving the growth for the Middle-East and Africa colorectal cancer market. Major drugs manufacturers are investing amount of money for R & D to find cure for colorectal cancer.
Increasing funding and overall increased expenditure for healthcare, developing infrastructure, and expanded insurance coverage are leading the growth for Middle-East and Africa Colorectal Cancer. Middle-East and Africa Colorectal Cancer Market was estimated around US$ 0.8 billion in 2015 and is expected to reach US$ 0.90 billion by 2022 at a CAGR of 1.8%. There are several factors which are prohibiting the growth of the market such as extremely high cost of cancer treatment and drugs, lack of early diagnosis, lack of awareness and healthcare facilities particularly in African countries etc.
Market Players:
F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (US), Novartis AG(Switzerland), Abbott (US), Beckman Coulter Inc. (US), Debiopharm Group (Switzerland), AbbVie Inc. (US), Bayer AG (Germany)
Regional Analysis:
Considering the Middle-East and Africa Colorectal Cancer Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Colorectal Cancer. Moreover Saudi Arabia market is also growing and second largest market for Patient monitoring devices. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Colorectal Cancer during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.
Access the market data and market information presented through more than 25 market data tables and 25 figures spread over 80 numbers of pages of the project report “Middle-East and Africa Colorectal Cancer Market- Forecast to 2022”
Market Segmentation:
Middle-East and Africa Colorectal Cancer market has been segmented on the basis of type which Adenocarcinomas, Carcinoid tumors, Gastrointestinal stromal tumors (GISTs), Lymphomas, Sarcomas, and others. On the basis of diagnosis the market is segmented into Faecal Occult Blood Test, Colonoscopy, Virtual Colonoscopy, Stool DNA test, Digital Rectal Examination, Flexible Sigmoidoscopy, Biopsy, Magnetic resonance imaging (MRI), and Others. On the basis of treatment type market is segmented into Surgery, Radiation Therapy, Chemotherapy, targeted drug therapy, and others.
Intended Audience
Access Report Details @ https://www.marketresearchfuture.com/reports/mea-colorectal-cancer-market-2551
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.